Skip to main content
Log in

Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents

  • Original paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Although in-stent restenosis (ISR) occurs after drug-eluting stents (DES) implantation, neointimal tissue characteristics have not been fully investigated. We assessed neointimal tissue components using integrated backscatter intravascular ultrasound (IB-IVUS) after DES and bare-metal stents (BMS) implantation. Fifty-seven consecutive patients with 61 lesions underwent repeated percutaneous coronary intervention (PCI) for the treatment of ISR (DES: 24 lesions, BMS: 37 lesions). PCI was performed using plain old balloon angioplasty (POBA). Before PCI, we assessed neointimal tissue characteristics using IB-IVUS. Neointima was divided into four categories: category 1 (−11 to −29 dB), category 2 (−29 to −35 dB), category 3 (−35 to −49 dB), and category 4 (−49 to −130 dB) according to IB values. We compared neointimal tissue components between DES and BMS. Thirty-three patients with 33 lesions (DES: 17, BMS: 16) were finally included. Neointima was predominantly composed of category 3 tissue in both groups (DES: 68 ± 8%, BMS: 73 ± 5%, P = 0.053). DES had a broader distribution of category 4 tissue component than BMS. After POBA, distal slow flow phenomenon occurred in 5 of DES (29%), whereas none of BMS. In DES, the optimal threshold of category 4 tissue to predict distal slow flow phenomenon after POBA was 30% (sensitivity: 100%, specificity: 92%). Neointima was mainly composed of category 3 tissue at ISR site, irrespective of DES or BMS. In DES, there was a subgroup with category 4 rich tissue, which caused distal slow flow phenomenon after POBA. IB-IVUS might be useful to identify vulnerable neointima in DES restenosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF et al (1996) Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 94(6):1247–1254

    Article  PubMed  CAS  Google Scholar 

  2. Mehran R, Mintz GS, Hong MK, Tio FO, Bramwell O, Brahimi A et al (1998) Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes. J Am Coll Cardiol 32(3):794–799

    Article  PubMed  CAS  Google Scholar 

  3. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM (2000) Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 35(1):157–163

    Article  PubMed  CAS  Google Scholar 

  4. Murata T, Hiro T, Fujii T, Yasumoto K, Murashige A, Kohno M et al (2002) Impact of the cross-sectional geometry of the post-deployment coronary stent on in-stent neointimal hyperplasia: an intravascular ultrasound study. Circ J 66(5):489–493

    Article  PubMed  Google Scholar 

  5. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346(23):1773–1780

    Article  PubMed  CAS  Google Scholar 

  6. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350(3):221–231

    Article  PubMed  CAS  Google Scholar 

  7. Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W et al (2007) Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol 100(4):627–630

    Article  PubMed  CAS  Google Scholar 

  8. Kuriyama N, Kobayashi Y, Nakayama T, Kuroda N, Komuro I (2006) Images in cardiovascular medicine. Damage to polymer of a sirolimus-eluting stent. Circulation 114(20):e586–e587

    Article  PubMed  Google Scholar 

  9. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109(6):701–705

    Article  PubMed  Google Scholar 

  10. Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A et al (2002) Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 106(21):2649–2651

    Article  PubMed  CAS  Google Scholar 

  11. Kwon SW, Kim BK, Kim TH, Kim JS, Ko YG, Choi D et al (2011) Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound. Am Heart J 161(2):367–372

    Article  PubMed  Google Scholar 

  12. Okubo M, Kawasaki M, Ishihara Y, Takeyama U, Kubota T, Yamaki T et al (2008) Development of integrated backscatter intravascular ultrasound for tissue characterization of coronary plaques. Ultrasound Med Biol 34(4):655–663

    Article  PubMed  Google Scholar 

  13. Kawasaki M, Takatsu H, Noda T, Sano K, Ito Y, Hayakawa K et al (2002) In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 105(21):2487–2492

    Article  PubMed  Google Scholar 

  14. Okubo M, Kawasaki M, Ishihara Y, Takeyama U, Yasuda S, Kubota T et al (2008) Tissue characterization of coronary plaques: comparison of integrated backscatter intravascular ultrasound with virtual histology intravascular ultrasound. Circ J 72(10):1631–1639

    Article  PubMed  Google Scholar 

  15. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF et al (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100(18):1872–1878

    Article  PubMed  CAS  Google Scholar 

  16. Chieffo A, Foglieni C, Nodari RL, Briguori C, Sangiorgi G, Latib A et al (2009) Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. Am J Cardiol 104(12):1660–1667

    Article  PubMed  CAS  Google Scholar 

  17. Oikawa Y, Yajima J, Costa MA, Matsuno S, Akabane M, Funada R et al (2010) Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential “thromborestenosis” phenomenon. EuroIntervention 6(3):380–387

    Article  PubMed  Google Scholar 

  18. van Beusekom HM, Saia F, Zindler JD, Lemos PA, Swager-Ten Hoor SL, van Leeuwen MA et al (2007) Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur Heart J 28(8):974–979

    Article  PubMed  Google Scholar 

  19. Costa MA, Sabate M, Angiolillo DJ, Jimenez-Quevedo P, Teirstein P, Carter A et al (2006) Intravascular ultrasound characterization of the “black hole” phenomenon after drug-eluting stent implantation. Am J Cardiol 97(2):203–206

    Article  PubMed  CAS  Google Scholar 

  20. Goto K, Shiode N, Shirota K, Fukuda Y, Kitamura F, Tominaga K et al (2009) Pathological finding of sirolimus-eluting stent (SES) restenosis lesion with black hole appearance on intravascular ultrasound. Circ J 73(10):1969–1971

    Article  PubMed  Google Scholar 

  21. Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Lee CW et al (2010) Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am J Cardiol 106(11):1561–1565

    Article  PubMed  Google Scholar 

  22. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ et al (2011) Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 123(25):2954–2963

    Article  PubMed  CAS  Google Scholar 

  23. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y et al (2010) Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol 55(1):26–32

    Article  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinjo Sonoda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muraoka, Y., Sonoda, S., Kashiyama, K. et al. Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents. Int J Cardiovasc Imaging 28, 1635–1641 (2012). https://doi.org/10.1007/s10554-011-9997-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-011-9997-9

Keywords

Navigation